Greenmarket Report: Massachusetts Republican Wants to Cap Potential MDMA Therapy Costs

The bill – HD 2137, by state Rep. Nicholas Boldyga – was introduced in January, apparently in response to reporting by The Washington Post and The New York Times regarding moves by the nonprofit Multidisciplinary Association for Psychedelic Studies (MAPS), which estimated that the possible cost for MDMA treatments could reach as much as $13,000-$15,000 per patient, per visit.

Originally appearing here (Archived)